The Top 10 GI Trials at ASCO 2025 are here (with Dates and Times), and OncologyTube proudly presents an exclusive video to explore the latest breakthroughs in gastrointestinal oncology. This video highlights the most impactful trials at ASCO 2025, in Chicago from May 30 to June 3, 2025. Whether you’re a medical professional or a patient seeking advanced treatments, these trials provide valuable insights into the future of GI cancer care. Moreover, from the ATOMIC Trial to the POLCAGB Trial, the video covers innovative therapies that could transform lives. Therefore, watch the video above to learn more, and continue reading for a detailed summary of each trial. Stay informed with OncologyTube’s updates on oncology research!
Watch the Top 10 GI Trials at ASCO 2025 Video
OncologyTube created a comprehensive video to guide you through the Top 10 GI Trials at ASCO 2025. For instance, this exclusive, released on May 28, 2025, breaks down each trial in a concise and engaging way. As a result, you can quickly understand the significance of these studies. Additionally, the video is embedded below for easy access.
Summary of the Top 10 GI Trials at ASCO 2025
Here’s a brief overview of the trials featured in the video. Consequently, each trial marks a step forward in gastrointestinal cancer research.
- #10: POLCAGB Trial
The POLCAGB Trial actively compares neoadjuvant chemotherapy with chemoradiotherapy for gallbladder cancer. It occurs on May 31 at 10:00 AM. - #9: Actuate 1801 Trial
This trial tests elraglusib alongside nab-paclitaxel and gemcitabine for pancreatic cancer. It takes place on June 1 at 2:00 PM. - #8: CheckMate 577 Trial
The CheckMate 577 Trial shares updated results on adjuvant nivolumab for esophageal cancers. For example, it’s scheduled for May 31 at 3:00 PM CT. - #7: ANCHOR Trial
This trial compares anlotinib with bevacizumab for metastatic colorectal cancer. It happens on May 30 at 2:45 PM CT. - #6: BREAKWATER Trial
The BREAKWATER Trial provides updates on encorafenib, cetuximab, and mFOLFOX6 for colorectal cancer. Moreover, it’s presented on May 30 at 2:45 PM CT.
More Groundbreaking GI Trials at ASCO 2025
Continuing our list of the Top 10 GI Trials at ASCO 2025, here are the next five trials you should know about. Thus, these trials offer more insights into GI oncology.
- #5: LBA4004 Trial
The LBA4004 Trial compares preoperative mFOLFIRINOX with PAXG for pancreatic cancer. It occurs on May 30 at 2:45 PM CT. - #4: DESTINY-Gastric04 Trial
This study compares trastuzumab deruxtecan with ramucirumab for GEJ cancer. It takes place on May 31 at 3:00 PM CT. - #3: DYNAMIC-III Trial
The DYNAMIC-III Trial uses ctDNA-guided chemotherapy for stage III colon cancer. For instance, it’s presented on May 30 at 2:45 PM CT. - #2: MATTERHORN Trial
This trial evaluates perioperative durvalumab plus FLOT for gastric cancers. It happens on June 1 at 1:00 PM CT. - #1: ATOMIC Trial
The ATOMIC Trial tests adjuvant FOLFOX with atezolizumab for colon cancer. Additionally, it’s scheduled for June 1 at 1:00 PM CT.
Why These Trials Matter for GI Oncology
These trials hold great importance because they tackle critical gaps in GI cancer treatment. For example, the ATOMIC Trial explores new adjuvant therapies, while the POLCAGB Trial focuses on gallbladder cancer, a less common but aggressive disease. Therefore, watching the video helps you understand how these studies might impact patient care.
Stay Updated with OncologyTube
OncologyTube serves as your go-to source for the latest in oncology research. For instance, check out our related video on ASCO 2025 highlights for more insights. Additionally, visit the official ASCO 2025 website at https://www.asco.org for the full conference schedule. Finally, follow us on X for real-time updates using #ASCO25 and #Glonc.